Please use this identifier to cite or link to this item: http://nopr.niscair.res.in/handle/123456789/6339
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGeorge, M Rosalind-
dc.contributor.authorMaharajan, A-
dc.contributor.authorJohn, K Riji-
dc.contributor.authorJeyaseelan, M J Prince-
dc.date.accessioned2009-10-30T12:04:36Z-
dc.date.available2009-10-30T12:04:36Z-
dc.date.issued2006-01-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/6339-
dc.description63-67en_US
dc.description.abstractTaking an innovative approach, a vaccination study using five bacterial strains viz. Vibrio campbelli (B60), V. alginolyticus (B73), V. parahaemolyticus-like (B79), V. parahaemolyticus (R8) and V. harveyi (RG203) was conducted in Penaeus monodon against white spot syndrome virus (WSSV) infection, considered as one of the serious pathogens of shrimps. Oral challenge with shrimps infected with WSSV showed a relative percentage survival of 5 and 47 % in the P. monodon juveniles vaccinated with V. parahaemolyticus and V. harveyi, respectively. Results showed that there is a possibility of specifically immunising the shrimps against WSSV using bacterin prepared out of Vibrio harveyi isolates taken from shrimps infected with WSSV. Also, there was a level of protection attained by the shrimps due to immunisation with Vibrio strains.en_US
dc.language.isoen_USen_US
dc.publisherCSIRen_US
dc.sourceIJEB Vol.44(01) [January 2006]en_US
dc.subjectBacterinen_US
dc.subjectPenaeus monodonen_US
dc.subjectShrimpen_US
dc.subjectVaccinationen_US
dc.subjectVibrio harveyien_US
dc.subjectWhite spot syndrome virusen_US
dc.titleShrimps survive white spot syndrome virus challenge following treatment with vibrio bacterinen_US
dc.typeArticleen_US
Appears in Collections:IJEB Vol.44(01) [January 2006]

Files in This Item:
File Description SizeFormat 
IJEB 44(1) 63-67.pdf62.86 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.